stella
beta
A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis — Stella
Recruiting
Back to Palmoplantar Pustulosis (PPP) trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Xijing hospital, Xi'an, Shaanxi
View full record on ClinicalTrials.gov